Health Dictionary Find a Doctor

Chylomicron

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]

Overview

Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.

References

Template:WikiDoc Sources

Historical Perspective

Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.

References

Template:WikiDoc Sources

Classification

Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.

References

Template:WikiDoc Sources

Biochemistry

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Biochemistry

Structure

Lipoprotein Density Size % Protein % Cholesterol % Triglyceride Major Lipid Apolipoprotein
Chylomicron

For more information about the biochemistry of all lipoproteins, click here.

Chylomicron Receptors

Enzymes Associated with Chylomicron

References

Template:WikiDoc Sources

Physiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Chylomicrons are large lipoprotein particles (having a diameter of 75 to 1,200nm) that are created by the absorptive cells of the small intestine.The chylomicrons are released by exocytosis from enterocytes into lacteals, lymphatic vessels originating in the villi of the small intestine, and are then secreted into the bloodstream at the thoracic duct’s connection with the left subclavian vein. Chylomicrons transport exogenous lipids to liver, adipose, cardiac and skeletal muscle tissue where they are broken down by lipoprotein lipase into very low density lipoproteins (VLDLs).

Contents when released

Nascent chylomicrons are primarily composed of triglycerides (85%) and contain some cholesterol and cholesteryl esters. The main apolipoprotein component is apolipoprotein B-48 (APOB48).

Changes during circulation

While circulating in lymph and blood, chylomicron exchanges components with High Density Lipoproteins (HDL). The HDL donates apolipoprotein C-II (APOC2) and apolipoprotein E (APOE) to the nascent chylomicron and thus matures it into a “chylomicron.” APOC2 is the cofactor for lipoprotein lipase (LPL) activity. Once triglyceride stores are distributed, the chylomicron returns APOC2 (but keeps APOE) back to the HDL and thus becomes a chylomicron remnant. APOB48 and APOE are important to identify the chylomicron remnant in the liver for endocytosis and breakdown.

de:Chylomikron it:Chilomicroni nl:Chylomicron fi:Kylomikroni sv:Kylomikron

Template:WS

Clinical Correlation

Clinical Correlation

Definition | Epidemiology and Demographics | Pathophysiology | Causes | Prognosis and Complications

Definition | Epidemiology and Demographics | Epidemiology and Demographics | Pathophysiology | Causes | Prognosis and Complications

Treatment

Treatment

Medical Therapy | Primary Prevention | Secondary Prevention | Landmark Trials | Future or Investigational Therapies


Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH